patients with stage iv or recurrent adenocarcinoma of the lung

Showing 1 - 1 of 1

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Patients With Stage IV or Recurrent Adenocarcinoma of the Lung Trial (Abraxane, Gemcitabine)

Completed
  • Patients With Stage IV or Recurrent Adenocarcinoma of the Lung
  • (no location specified)
Sep 28, 2021